Acetazolamide

乙酰唑胺

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameAcetazolamide
Drug Alias NameAcetazolamidum乙醯偶氮胺Acetazolamida迪阿莫克斯碳酸酐酶抑制剂乙酰唑胺 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarbonic anhydrases inhibitors
TargetsCarbonic anhydrases
Therapy Area/IndicationsAcutely decompensated congestive heart failureSchizophreniaOpioid-Related Disorders +[26] 
Global Approved IndicationsGlaucomaOcular HypertensionEpilepsy
Approved Indications in ChinaGlaucomaOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1953/07/27
Country/TerritoryCanadaUnited StatesSweden +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeva
China Registration ClassN/A

Develop Information

Active CompaniesThe Brigham and Women's HospitalUniversity of ZurichThe University Of Arizona +[10] 
Inactive CompaniesJaeb Center For Health Research IncStanford UniversitySt. Luke'S Roosevelt Hospital Center Foundation Inc +[10] 
Active IndicationsAcutely decompensated congestive heart failureSchizophreniaOpioid-Related Disorders +[16] 
Inactive IndicationsHypertensionMacular EdemaSleep Wake Disorders +[10] 

Other Information

ATC CodeS01EC01
Related LinksWikipediaDrugBankKEGG